The Zucker Hillside Hospital
Welcome,         Profile    Billing    Logout  
 13 Trials 
11 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Correll, Christoph U
AVIS, NCT02357797: Adjunctive Vortioxetine in Schizophrenia

Active, not recruiting
4
88
US
Vortioxetine, Brintellix, Placebo
Northwell Health, Takeda
Schizophrenia, Negative Symptoms
10/23
06/24
STEP-ENHANCE, NCT06778564: Stratification and Treatment in Early Psychosis Study - ENHANCE

Not yet recruiting
3
250
Europe, RoW
CBD 100 mg/mL Oral Solution, Placebo
University of Oxford, Wellcome Trust, GW Pharmaceuticals Ltd, Myonex, Cambridge Cognition Ltd, Premier Research Group plc, Diagram B.V., Cambridgeshire and Peterborough NHS Foundation Trust, Oxford Health NHS Foundation Trust, West London NHS Trust, University of Augsburg, Charite University, Berlin, Germany, University of Cologne, Ludwig Maximilian university of Munich, The Sheba Fund for Health Services and Research, Shalvata Mental Health Center, Geha Mental Health Center, Amsterdam University Medical Center, Hospital General Universitario Gregorio Marañon, National and Kapodistrian University of Athens, Medical University of Vienna, Hospitales Universitarios Virgen del Rocío, University of Campania Luigi Vanvitelli, Swansea University, Psychiatric University Hospital, Zurich, IDEA Regulatory
Psychosis, First Episode Psychosis, Psychotic Disorders, Psychotic Episode
12/27
12/28
OASIS-D, NCT04404309: Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression

Recruiting
N/A
3331
Europe
Charite University, Berlin, Germany, Janssen-Cilag G.m.b.H
Depression, Depression Moderate, Depression Severe, Suicidal and Self-injurious Behavior, Suicidal Ideation, Suicide, Attempted
12/24
12/24
RESHAPE, NCT05480046: Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Recruiting
N/A
1200
Europe
Risperidone ISM, OKEDI®
Rovi Pharmaceuticals Laboratories
Schizophrenia
12/24
12/24
FIAT, NCT06759402: Family-based Telemedicine Vs. Inpatient Anorexia Nervosa Treatment

Not yet recruiting
N/A
200
NA
Family based treatment, Inpatient multimodal therapy
Charite University, Berlin, Germany, Bielefeld University, Techniker Krankenkasse, BARMER, AOK Niedersachsen, Mobil Krankenkasse, Meine Krankenkasse, Medicalnetworks CJ GmbH & Co.KG, AOK Baden-Württemberg, DAK Gesundheit, BIG-direkt, mhplus, Bahn-BKK, OFFIS - Institut für Informatik, Prof. Daniel Le Grange, UCSF
Anorexia Nervosa, Anorexia in Adolescence
03/27
12/27
Braga, Raphael J
ENLIGHTEN, NCT05113771: A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With Treatment-Resistant Depression

Completed
2
197
Canada, US
Liafensine, Placebo
Denovo Biopharma LLC
Treatment Resistant Depression
02/24
03/24
Gallego, Juan
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, )

Recruiting
3
450
Europe, US, RoW
Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio
Evopoint Biosciences Inc.
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
04/25
12/25
NCT06702449: A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Recruiting
1/2
448
Europe, US, RoW
Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine medium dose formulation 1, Candidate UTI vaccine medium dose formulation 2, Candidate UTI vaccine high dose formulation 1, Candidate UTI vaccine high dose formulation 2, Candidate UTI vaccine HTD formulation 2, Placebo
GlaxoSmithKline
Urinary Tract Infections
08/27
08/27
Argyelan, Miklos
NCT06096207: DBS for Depression

Recruiting
1
20
US
Medtronic SenSight Directional DBS lead
Northwell Health, Medtronic
Treatment Resistant Depression
10/30
10/38
NCT02773082: DBS for Obsessive-Compulsive Disorder

Recruiting
N/A
50
US
Reclaim™ DBS Therapy
Northwell Health, Medtronic
Obsessive-Compulsive Disorder (OCD)
01/30
01/30
Kirschenbaum, Michael
NCT03788811: ERG Components in Schizophrenia and Bipolar Disorder Type I

Active, not recruiting
N/A
300
Canada, US, RoW
ERG assessment (RSPA)
diaMentis Inc.
Schizophrenia, Bipolar I Disorder
12/24
12/24

Download Options